Zusammenfassung
Kognitive und motorische Leistungsminderungen von Hirnregionen im Alter gehören zu den gravierendsten Einschränkungen der Lebensqualität. Die zellulären und molekularen Mechanismen, die zu den Leistungsminderungen führen, und die möglichen vorbeugenden Maßnahmen werden daher intensiv untersucht. Wesentliche Faktoren für die altersbedingten Leistungsverluste sind: zunehmende zelluläre und molekulare Schäden, altersabhängige Veränderungen der Genexpression z. B. bei Langlebigkeitsgenen wie Klotho und ihren Polymorphismen, Veränderungen von Wachstumsfaktoren und Hormonen, dadurch bedingte strukturelle Veränderungen von Neuronen wie eine verringerte Zahl von Dendriten und Synapsen sowie Zellverluste durch Apoptose.
Funktionelle Veränderungen betreffen eine Reihe von kognitiven und motorischen Funktionen wie die Geschwindigkeiten von Wahrnehmungen, von Reaktionen, Entscheidungen, von Orientierung, Wortfindung, Sprache und von motorischen Abläufen sowie die verringerte Kapazität und Abrufbarkeit von Gedächtnisinhalten. Eine Aktivierung dieser Leistungsbereiche wird daher als vorbeugende Maßnahme empfohlen. Auch eine Veränderung des Schlaf-Wach-Verhaltens gehört mit zu den »normalen« Alterungserscheinungen, während Depressionen eher durch die veränderten Lebensbedingungen (Altersheim, Pflege) zunehmen. Eine gravierende Alterskrankheit ist die Alzheimer-Krankheit (AD), die sich in allgemein zunehmender Demenz und Gedächtnisverlust bemerkbar macht und die bisher nicht heilbar ist. Dagegen lässt sich die Parkinson-Krankheit (PD) durch die Gabe von DOPA, einer Vorläufersubstanz von Dopamin, deutlich verzögern.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Arking R (1991) Biology of aging; observations and principles. Prentice Hall, Englewood Cliffs
Bali J, Halima SB, Felmy B, Goodger Z, Zurbriggen S, Rajendran L (2010) Cellular basis of Alzheimer’s disease. Ann Indian Acad Neurol 13(Suppl 2):89–93
Becker JT, Overman AA (2002) The semantic memory deficit in Alzheimer’s disease. Rev Neurol 35:777–783
Cajochen C, Münch M, Knoblauch V, Blatter K, Wirz-Justice A (2006) Age-related changes in the circadian and homeostatic regulation of human sleep. Chronobiol Int 23:461–474
Chan SL, Wei Z, Chigurupati S, Tu W (2010) Compromised respiratory adaptation and thermoregulation in aging and age-related diseases. Ageing Res Rev 9:20–40
Chen-Plotkin AS, Lee VM, Trojanowski JQ (2010) TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol 6:211–220
Conde JR, Streit WJ (2006) Microglia in the aging brain. J Neuropathol Exp Neurol 65:199–203
Davidson PS, Cook AP, Glisky EL (2006) Flashbulb memories for September 11th are preserved in older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 13:196–206
De Kosky ST, Fitzpatrick A, Ives DG, Saxton J et al (2006) The Ginkgo evaluation of memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 27:238–253
Dickstein DL, Kabaso D, Rocher AB, Luebke JI et al (2007) Changes in the structural complexity of the aged brain. Aging Cell 6:275–284
Ding Q, Huo L, Yang JY, Xia W et al (2008) Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res 68:6109–6117
Driver JA, Beiser A, Au R, Kreger BE et al (2012) Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study. BMJ 344:e442
Duan H, Wearne SI, Rocher AB, Macedo A et al (2003) Age-related dendrite and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb Cortex 13:950–961
Dunlap JC, Loros JJ, Colot HV, Mehra A et al (2007) A circadian clock in Neurospora: how genes and proteins cooperate to produce a sustained, entrainable, and compensated biological oscillator with a period of about a day. Cold Spring Harb Symp Quant Biol 72:57–68
Eller M, Williams DR (2011) Review: α-Synuclein in Parkinson disease and other neurodegenerative disorders. Clin Chem Lab Med 49:403–408
Erraji-Benchekroun L, Underwood MD, Arango V, Galfalvy H et al (2005) Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 57:549–558
Fjell AM, Walhovd KB (2010) Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci 21:187–221
Fuchs GA (2002) Die Parkinson’sche Krankheit: Ursachen und Behandlungsformen. C. H. Beck, München
Glisky EL (2007) Changes in cognitive function in human aging. In: Riddle DR (ed) Brain aging: models, methods, and mechanisms. CRC, Boca Raton
Glorioso C, Sibille E (2011) Between destiny and disease: Genetics and molecular pathways of human central nervous system aging. Progress in Neurobiol 93:165–181
Glorioso CA, Sunghee Oh, Douillard GG, Sibille E (2011) Brain molecular aging, promotion of neurological disease and modulation by Sirtuin 5 longevity gene polymorphism. Neurobiol Dis 41:279–290
Good CD, Johnsrude IS, Ashburner J, Henson RN et al (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36
Govoni S, Amadio M, Battaini F, Pascale A (2010) Senescence of the brain: focus on cognitive kinases. Curr Pharm Des 16:660–671
Grady CJ (2008) Cognitive Neuroscience of aging. Ann NY Acad Sci 1124:127–144
Green BH, Copeland JR, Dewey ME, Sharma V et al (1992) Risk factors for depression in elderly people: a prospective study. Acta Psychiatr Scand 86:213–217
Harten AC van, Kester MI, Visser PJ, Blankenstein MA, Pijnenburg YA, Flier WM van der, Scheltens P (2011) Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 49:353–366
Holowatz LA, Kenney WL (2010) Peripheral mechanisms of thermoregulation control of skin blood flow in aged humans. J Appl Physiol 109:1538–1544
Humpel C (2011) Identifying and validating biomarkers for Alzheimer’s disease. Trends Biotechnol 29:26–32
Iliff JJ, Wang M, Liao Y, Plogg BA (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including Amyloid β. Sci Transl Med 4:147ra111
Jellinger KA (2009) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730–740
Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, Bussche van den H (2005) Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomized clinical trials. BMJ 331:321–327
Kandel E, Schwartz J, Jessel TM (2000) The Principles of neural science, 4. Aufl. McGraw-Hill, New York
Kleinschnitz C, Grund H, Wingler K, Armitage ME et al (2010) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 8(9) pii: e1000479
Kruman JJ, Kumaravel TS, Lohani A et al (2002) Folic acid deficiency and homocystein impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci 22:1752–1762
Mattson MP (2008) Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann NY Acad Sci 1144:97–112
Mattson MP, Maudsley S, Martin B (2004) A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res Rev 3:445–464
McKeith IG, Galasko D, Kosaka K, Perry EK et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124
Morrison JH, Baxter MG (2012) The ageing cortical synapse: hallmarks and implications for cognitive decline. Nature Reviews Neuroscience 13:240–250
Mucke L (2009) Neuroscience: Alzheimer’s disease. Nature 461:895–897
Nagahara AH, Merrill DA, Coppola G, Tsukada S (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models. Nat Med 15:331–337
Nixon RA, Yang DS (2011) Autophagy failure in Alzheimer’s disease - locating the primary defect. Neurobiol Dis 43:38–45
Nyberg L, Lövdén M, Riklund K, Lindenberger U et al (2012) Memory aging and brain maintenance. Trends Cogn Sci 16:292–305
O’Hara R, Schroder CM, Mahadevan R, Schatzburg AF et al (2007) Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol Psychiatry 12:544–555
Pace-Schott EF, Spencer RM (2011) Age-related changes in the cognitive function of sleep. Prog Brain Res 181:75–89
Park DC, Reuter-Lorenz P (2009) The adaptive brain: aging and neurocognitive scaffolding. Ann Rev Psychol 60:173–196
Persson J, Nyberg L (2006) Altered brain activity in healthy seniors: what does it mean? Prog Brain Res 157:45–56
Peters M (2004) Klinische Entwicklungspsychologie des Alters. Vandenhoeck & Ruprecht, Göttingen
Peters A, Sethares C, Luebke JI (2008) Synapses are lost during aging in the primate prefrontal cortex. Neuroscience 152:970–981
Ray S (2007) Classification and prediction of clinical Alzheimer’s diagnosis based on plasma signaling proteins. Nat Med 13:1359–1362
Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137–152
Rensing L (1989) Chronobiologie des Alterns. Veränderungen der zeitlich-periodischen Ordnung. Z Gerontol 22:73–78
Rensing L, Koch M, Rippe B, Rippe V (2006) Mensch im Stress. Psyche, Körper, Moleküle. Spektrum/Elsevier, Heidelberg
Rensing L, Koch M, Ruoff P (2007) Molekulare Mechanismen der neuronalen und immunologischen Gedächtnisse. Naturwiss Rundschau 60:61–70
Resnick SM, Sojkova J (2011) Amyloid imaging and memory change for prediction of cognitive impairment. Alzheimers Res Ther 3:3
Reznick RM, Zong H, Li J, Morino K et al (2007) Aging-associated reduction in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab 5:151–156
Robinson RA, Lange MB, Sultana R, Galvan V et al (2011) Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein. Neuroscience 177:207–222
Rossum van IA, Voss S, Handels R, Visser PJ (2010) Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design. J Alzheimers Dis 20:881–891
Roth G (2009) Persönlichkeit, Entscheidung und Verhalten. Klett-Cotta, Stuttgart
Sastre M et al (2006) Non steroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPAR gamma. Proc Natl Acad Sci USA 103:443–448
Schuurman AG, Akker van den M, Ensinck KTJL, Metsemakers JFM et al (2000) Increased risk of Parkinson’s disease after depression. Neurology 58:1501–1504
Sharma S, Rakoczy S, Brown-Borg H (2010) Assessment of spatial memory in mice. Life Sci 87:521–536
Sporns O (2010) Networks of the Brain. MIT-Press, Cambridge (USA
Stranahan AM, Mattson MP (2012) Recruiting adaptive cellular stress responses for successful brain aging. Nature Reviews Neuroscience 13:209–216
Terry AV Jr, Callahan PM, Hall B, Webster SJ (2011) Alzheimer’s disease and age-related memory decline (preclinical). Pharmacol Biochem Behav 99:190–210
Tijn van P, Kamphuis W, Marlatt MW, Hol EM, Lucassen PJ (2011) Presenilin mouse and zebrafish models for dementia: focus on neurogenesis. Prog Neurobiol 93:149–164
Twamley EW, Ropacki SA, Bondi MW (2006) Neuropsychological and neuroimaging changes in preclinical Alzheimer disease. J Int Neuropsychol Soc 12:707–735
Varanese S, Birnbaum Z, Rossi R, Di Rocco A (2011) Treatment of advanced Parkinson’s disease. Parkinsons Dis 2010:480260
Wang M, Gamo NJ, Yang Y, Jin LE et al (2011) Neuronal base of age-related working memory decline. Nature 476:210–213
Weinmann S, Roll S, Schwarzbach C, Vauth G et al (2010) Effects of Gingko biloba in dementia: Systematic review and metaanalysis. BMC Geriatr doi:101186/1471-2318
Wilkins CH, Mathews J, Sheline YI (2009) Late life depression with cognitive impairment: evaluation and treatment. Clin Interv Aging 4:51–57
Yamauchi T (2005) Neuronale Ca2+/Calmodulin-dependent protein kinase II – discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull 28:1342–1354
Zhang Y, Thompson R, Zhang H, Xu H (2011) APP processing in Alzheimer’s disease. Mol Brain 4:3
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rensing, L., Rippe, V. (2014). Das Zentralnervensystem. In: Altern. Springer Spektrum, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37733-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-37733-4_12
Published:
Publisher Name: Springer Spektrum, Berlin, Heidelberg
Print ISBN: 978-3-642-37732-7
Online ISBN: 978-3-642-37733-4
eBook Packages: Life Science and Basic Disciplines (German Language)